There’s a very nice article in the New York Times today [Promise Seen in Drug for Retardation Syndrome] about a human clinical trial testing a drug to improve behavior in those with Fragile X syndrome (FXS), a genetic disorder associated with intellectual disability and behavior problems, among other issues.  The article traces the long path that led to the development of drugs for FXS.   The results of the clinical trial are not yet published and larger studies will

So, here's a different approach.  A new study looks at the use of a computerized device in helping to modify eating behavior in typically developing obese adolescents.  Treatment of childhood obesity by retraining eating behaviour: randomized controlled trial examines the use of a Mandometer, which provides real time feedback during meals.  Originally developed for people eating disorders such as anorexia, this

Although it's rarely mentioned in clinical descriptions of PWS, anyone who hangs around families with PWS knows that seizures seem to occur much more frequently in those with PWS than typical individuals. Even in cases where a seizure disorder is never formally diagnosed, many parents have, at one time or another, had their child with PWS evaluated because they appear to be having seizures or unusual movements.

This project was funded by the Foundation for Prader Willi Research in 2006 and conducted by Drs. Gregory Olley and Anne Wheeler and their team at the University of North Carolina, Chapel Hill (UNC), Center for Development and Learning. Dr. Wheeler is currently finishing the analysis and preparing publications from the study. Following publication, a more detailed analysis will be available, but Dr.